Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Update France.
Press releases published on April 15, 2025
HK Refurbished Stock établit une nouvelle référence sur le marché mondial des iPhones reconditionnés en gros
EIN Presswire
·
April 15, 2025
Expédition locale depuis l’UE …
Balfour Capital Welcomes Katoucha Mauron as Investment Advisor
EIN Presswire
·
April 15, 2025
Hedge Funds, Investments, Trading YVERDON-LES-BAINS, SWITZERLAND, April 15, 2025 /EINPresswire.com/ -- Balfour Capital Group Welcomes Katoucha Mauron, Strengthening Global Talent and Innovation Across Finance and Strategy Balfour Capital Group (BCG), …
Lucia Magnani Health Clinic Earns Two Major 2025 Wellness Awards
EIN Presswire
·
April 15, 2025
MILAN, MILAN, ITALY, April 15, 2025 /EINPresswire.com/ -- The Lucia Magnani Health Clinic has been awarded Best Medical SPA 2025 at the Italian SPA Awards 2025 and listed among the most iconic SPAs of 2025 by the prestigious international guide Condé …
Inventiva announces filing of its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F
GlobeNewswire
·
April 15, 2025
Daix (France), New York City (New York, United States), April 15, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for …
Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2024 et de son Rapport Annuel 2024 (« Form 20-F »)
GlobeNewswire
·
April 15, 2025
Daix (France), New York City (New York, États-Unis), le 15 avril 2025 - Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par …
Results of the Stellantis 2025 Annual General Meeting
GlobeNewswire
·
April 15, 2025
Results of the Stellantis 2025 Annual General Meeting AMSTERDAM, April 15, 2025 - Stellantis N.V. (“Stellantis”) announced today that all resolutions submitted to the shareholders for approval at the Annual General Meeting (AGM), which was held in person …
Constellium posts 2025 Annual General Meeting Materials
GlobeNewswire
·
April 15, 2025
PARIS, April 15, 2025 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) (the “Company”) today announced that the Proxy Statement filed on Form 8-K and other documents for the Company’s Annual General Meeting of Shareholders to be held on May 15, 2025, at 5 …
Vallourec Invitation: Q1 2025 Results Release and Conference Call - Thursday, May 15th, 2025
GlobeNewswire
·
April 15, 2025
Q1 2025 Results Release and Conference Call Thursday, May 15th, 2025 Vallourec will publish First Quarter 2025 Results on May 15th, 2025 at 07:30 AM CET. Philippe Guillemot, Chairman of the Board and Chief Executive Officer, and Sascha Bibert, Chief …
Publicis Groupe : First Quarter 2025 Revenue
GlobeNewswire
·
April 15, 2025
Very strong Q1 at +4.9% Confirming guidance after record new business run April 15, 2025 Net revenue up 9.4% in Q1, including organic growth of +4.9% All regions performing well despite challenging global context €500 million M…
Publicis Groupe : Revenu du premier trimestre 2025
GlobeNewswire
·
April 15, 2025
Très bon 1er trimestre à +4,9 % Confirmation des prévisions après des gains de budgets records 15 avril 2025 Revenu net en hausse de 9,4 % au 1er trimestre, incluant une croissance organique de +4,9 % Très bonne performance de toutes les régions malgré un …
Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD
GlobeNewswire
·
April 15, 2025
Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD New phase 2 data for amlitelimab show efficacy in heterogeneous inflammatory asthma Lunsekimig now targeting chronic rhinosinusitis and COPD in …
Communiqué de presse : Le portefeuille de traitements contre les maladies respiratoires de Sanofi s’enrichit de nouvelles données sur l’asthme et prévoit de nouvelles études cliniques sur la BPCO
GlobeNewswire
·
April 15, 2025
Le portefeuille de traitements contre les maladies respiratoires de Sanofi s’enrichit de nouvelles données sur l’asthme et prévoit de nouvelles études cliniques sur la BPCO De nouvelles données de phase II démontrent l’efficacité de l’amlitélimab dans le …